Skip to content
Search

Latest Stories

Pharmacy’s role in reducing NHS’ carbon emissions highlighted at Welsh Senedd

Pharmacy’s role in reducing NHS’ carbon emissions highlighted at Welsh Senedd

Medicines account for about 25 per cent of carbon emissions within the NHS

Members of the Royal Pharmaceutical Society (RPS) highlighted the work of pharmacists in making medicines use and the whole NHS more environmentally sustainable at the Welsh Senedd this week.


Politicians present were informed that around 25 per cent of the NHS’ carbon emissions result from medicines use, and therefore pharmacists’ expert skills are crucial for reducing these emissions.

RPS Wales Director, Elen Jones, was among the RPS staff who attended the event, which was co-hosted with the Association of the British Pharmaceutical Industry.

Commenting on the event, Elen said: “It was great to get so many productive conversations with the politicians to highlight the great work pharmacists are already doing in the sustainability field and to explain what further steps are required to reduce the negative environmental and ecological impact of medicines.”

She was joined by three RPS expert members who have been trailblazers for climate action within the profession:

  • Yasmina Hamdaoui, Pre-Operative Assessment Pharmacist at Betsi Cadwaladr UHB & co-founder of Ysbyty Gwynedd Green Group.
  • Andy Evans, Owner of JDS Evans Pharmacy in Newport, the first Net Zero pharmacy in Wales.
  • Minna Eii, NHS England’s Chief Sustainability Officer's Clinical Fellow and Lead Author of upcoming RPS Greener Pharmacy Guides.

Elen thanked Yasmina, Andy and Minna for “the fantastic work they’ve undertaken in recent years”, and for helping bring their “key points to life for the politicians.”

Climate change is the most significant health threat modern society has ever faced: it affects clean air, safe drinking water, food and shelter.

In September 2021, the RPS formally recognised the climate and ecological emergency by publishing a declaration on reducing the environmental harm from medicines.

As experts in medicine, pharmacists can take a leading role in reducing the environmental impact of medicines use, but pharmacies cannot do this alone.

Therefore, the Royal Pharmaceutical Society is calling on the pharmaceutical industry, governments across GB and other stakeholders to join them to make the changes required to tackle the climate emergency.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less